K102541 is an FDA 510(k) clearance for the CYNOSURE CELLULAZE LASER. Classified as Laser, Cellulite Appearance (product code OYW), Class II - Special Controls.
Submitted by Cynosure, Inc. (Wesford, US). The FDA issued a Cleared decision on January 26, 2012 after a review of 510 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General & Plastic Surgery submissions.
View all Cynosure, Inc. devices